CL2004000352A1 - USE OF COMPOUNDS DERIVED FROM STAUROSPORINE TO POTENTIATE THE FUNCTION OF COLLERGENIC, ESTRIATED NEURONES, BASAL AND SENSORY PROSENCEFALO. - Google Patents

USE OF COMPOUNDS DERIVED FROM STAUROSPORINE TO POTENTIATE THE FUNCTION OF COLLERGENIC, ESTRIATED NEURONES, BASAL AND SENSORY PROSENCEFALO.

Info

Publication number
CL2004000352A1
CL2004000352A1 CL2004000352A CL2004000352A CL2004000352A1 CL 2004000352 A1 CL2004000352 A1 CL 2004000352A1 CL 2004000352 A CL2004000352 A CL 2004000352A CL 2004000352 A CL2004000352 A CL 2004000352A CL 2004000352 A1 CL2004000352 A1 CL 2004000352A1
Authority
CL
Chile
Prior art keywords
staurosporine
prosencefalo
estriated
collergenic
neurones
Prior art date
Application number
CL2004000352A
Other languages
Spanish (es)
Inventor
Michael E Kauer James Ne Lweis
Original Assignee
Cephalon Inc & Kyowa Hakko Kog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40261177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2004000352(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cephalon Inc & Kyowa Hakko Kog filed Critical Cephalon Inc & Kyowa Hakko Kog
Publication of CL2004000352A1 publication Critical patent/CL2004000352A1/en

Links

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS DERIVADOS DE K-252a, ASI COMO A NUEVOS DERIVADOS DE ESTAUPORINA BIS-N-SUSTITUIDOS. LA INVENCION SE REFIERE TAMBIEN A UN METODO PARA TRATAR CELULAS NEURONALES ENFERMA QUE IMPLICA LA ADMINISTRACION DE LOS NUEVOS DERIVADOS ESTAUROSPORINA O DERIVADOS FUNCIONALES DE K-252a ESPECIFICADOS.THE INVENTION REFERS TO NEW DERIVATIVES OF K-252a, AS WELL AS NEW DERIVATIVES OF BIS-N-SUBSTITUTED STAUPORINE. THE INVENTION IS ALSO REFERRED TO A METHOD FOR TREATING NEURONAL CELLS THAT IMPLIES THE ADMINISTRATION OF THE NEW STAUROSPORINE DERIVATIVES OR FUNCTIONAL DERIVATIVES OF K-252a SPECIFIED.

CL2004000352A 1998-05-26 2004-02-24 USE OF COMPOUNDS DERIVED FROM STAUROSPORINE TO POTENTIATE THE FUNCTION OF COLLERGENIC, ESTRIATED NEURONES, BASAL AND SENSORY PROSENCEFALO. CL2004000352A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75649498A 1998-05-26 1998-05-26

Publications (1)

Publication Number Publication Date
CL2004000352A1 true CL2004000352A1 (en) 2005-05-27

Family

ID=40261177

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2004000352A CL2004000352A1 (en) 1998-05-26 2004-02-24 USE OF COMPOUNDS DERIVED FROM STAUROSPORINE TO POTENTIATE THE FUNCTION OF COLLERGENIC, ESTRIATED NEURONES, BASAL AND SENSORY PROSENCEFALO.

Country Status (1)

Country Link
CL (1) CL2004000352A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11358972B2 (en) 2019-03-05 2022-06-14 Eisai R&D Management Co., Ltd. Pentacyclic heterocycles
US11420980B2 (en) 2019-03-05 2022-08-23 Eisai R&D Management Co., Ltd. Salt of pentacyclic compound and crystal thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11358972B2 (en) 2019-03-05 2022-06-14 Eisai R&D Management Co., Ltd. Pentacyclic heterocycles
US11420980B2 (en) 2019-03-05 2022-08-23 Eisai R&D Management Co., Ltd. Salt of pentacyclic compound and crystal thereof

Similar Documents

Publication Publication Date Title
AR020020A1 (en) COMPOSITION FOR CANCER TREATMENT AND METHOD USING SENAL TRANSDUCTION MODULATORS AND ESSENTIAL OILS OF NATURAL PLANTS AS SYNERGISTS FOR CONVENTIONAL TREATMENTS
UY27604A1 (en) CHEMICAL COMPOUNDS.
BR0215052A (en) Acaricidal compositions and methods
ECSP034797A (en) DIHIDRO-BENZO DERIVATIVES [b] [1,4] DIAZEPIN-2-ONA AS ANTAGONISTS II MGLUR2
TNSN06053A1 (en) 6-substituted anilino purines as rtk inhibitors
ECSP034924A (en) Substituted derivatives of 1-oxa-2,8-daza-spiro [4,5] dec-2-eno
NO961087L (en) K-252a derivatives that increase neurotrophin-induced activity
CO4340688A1 (en) QUINAZOLINE DERIVATIVES AND PROCEDURES FOR THE USE OF THE SAME, AS AGENTS AGAINST CANCER, IN MAMMALS.
ES2161442T3 (en) CORALINE ANALOGS AS TOPOISOMERASA INHIBITORS.
NO20022238D0 (en) Polycycloalkylpurines as adenosine receptor antagonists
PT797439E (en) USING PRAMIPEXOTE AS A NEUROPROTECTOR AGENT
ES2194314T3 (en) BENZOPIRAN DERIVATIVES SUBSTITUTED FOR THE TREATMENT OF INFLAMMATIONS.
PA8543201A1 (en) DERIVATIVES OF DIHIDRO-BENZO [B] [1,4] -DIAZEPIN-2-ONA AS ANTAGONISTS I OF mGluR2
ECSP045133A (en) BENZOXAZOLES REPLACED AND ANALOGS AS A STROGEN AGENTS
PE59999A1 (en) DERIVATIVES OF 1,3,8-TRIAZA-ESPIRO [4,5] DECAN-4-ONA-8-SUBSTITUTED
BR0309278A (en) Compound, composition, methods for modulating ksp kinesin activity, for inhibiting ksp, for the treatment of a cell proliferative disease, and use of a compound
DK1297013T3 (en) Use of TACI as antitumor agent
EE200300167A (en) Amidoalkylpiperidine and Piperazine Derivatives, Pharmaceutical Composition Containing Them, and Use of Compounds for the Treatment of Nervous System Disorders
BR0007864A (en) Compound, and, use of a compound
ES2195577T3 (en) EPOTILON DERIVATIVES, PROCEDURE FOR PREPARATION AND USE.
ECSP034531A (en) SUBSTITUTED DERIVATIVES OF C-CICLOHEXILMETILAMINA
DK1096936T3 (en) Treatment of dyskinesia using mu selective opioid antagonists
ES2043665T3 (en) 6,11-DIHIDRO-11- (4-PIPERIDILIDEN) -5H-BENZO- (5,6) -CICLOHEPTA- (1,2-B) -PIRIDINS AND COMPOSITIONS AND METHODS OF USE.
SV2002000062A (en) MONOFLUOROALQUILO DERIVATIVES REF. X-12964
AR020563A1 (en) TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE